Nitin Kaushal
Chairman at DELTA 9 CANNABIS INC.
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jack Ross | M | 59 | 10 years | |
| Raj Grover | M | 43 | 15 years | |
| Pedro Lichtinger | M | 70 |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 7 years |
| Kellen O'Keefe | M | 41 | 5 years | |
| Casey Hoyt | M | 46 | 18 years | |
| Michael Moore | M | 46 | 18 years | |
| Gregory Crawford | M | - | 8 years | |
| Diana Anglin | F | - | 5 years | |
| William Zehnder | M | 48 | 9 years | |
| Robbie Grossman | M | 50 | 12 years | |
| Cidnee Vaykovich | F | - |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | 7 years |
| Salpy Boyajian | F | - | 6 years | |
| James Lawson | M | 73 |
Delta 9 Bio-Tech LP
 Delta 9 Bio-Tech LP Pharmaceuticals: OtherHealth Technology Delta 9 Bio-Tech LP provides medicinal cannabis products. The company was founded by John Arbuthnot and Bill Arbuthnot in 2013 and is headquartered in Winnipeg, Canada. | 11 years |
| Eric Baum | M | 48 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | 6 years |
| William Frazier | M | 66 | 9 years | |
| Moses Dodo | M | 65 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 2 years |
| Alfred Baumeler | M | 59 | 9 years | |
| Joanne Duhoux-Defehr | F | 51 |
Delta 9 Bio-Tech LP
Delta 9 Bio-Tech LP Pharmaceuticals: OtherHealth Technology Delta 9 Bio-Tech LP provides medicinal cannabis products. The company was founded by John Arbuthnot and Bill Arbuthnot in 2013 and is headquartered in Winnipeg, Canada. | 8 years |
| Fotios Plakogiannis | M | 90 |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | - |
| David Beck | M | - | 4 years | |
| Trae Fitzgerald | M | 36 | 9 years | |
| John Arbuthnot | M | 70 | 12 years | |
| Randy Dobbs | M | 73 | - | |
| Michelle Kira Lee | F | 30 | 3 years | |
| Karl Cahill | M | 51 | 6 years | |
| Rapp Alyssa | F | 45 | - | |
| Barret Reykdal | M | - | 4 years | |
| Roy F. Waldron | M | 61 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 5 years |
| Andrew W. W. Cockwell | M | - | 4 years | |
| Bruce Greenstein | M | 55 | 6 years | |
| Arakelyan B. Pateel | F | - | - | |
| Renata Berlingo | F | - | - | |
| Kate Apiratanapimonchai | F | - | - | |
| Adnan Bashir | M | 54 | 3 years | |
| Michael Hynes | M | - | 6 years | |
| Andreas Palalas | M | - | 8 years | |
| Chakradhar Gade | M | - |
Beejapuri Dairy Pvt Ltd.
 Beejapuri Dairy Pvt Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Beejapuri Dairy Pvt Ltd. manufactures fresh buffalo and cow milk. The firm brings natural, fresh and unadulterated cow and buffalo milk directly to doorstep. The company was founded by Chakradhar Gade and Nitin Kaushal in 2013 and is headquartered in Gurugram, India. | 11 years |
| Andrew Wolff | M | 53 | 3 years | |
| Mohamad Hussein | M | - |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | - |
| Guy Beaudin | M | - | 3 years | |
| Aman Sood | M | - | 3 years | |
| Patrick Eagan | M | 45 | 4 years | |
| Andrew Ellis | M | - | 4 years | |
| Graham Rankin | M | 54 | 1 years | |
| Ashley McGrath | M | - | 6 years | |
| Stephen Fryer | M | 86 | 10 years | |
| Nicolas Marcoux | M | - |
PricewaterhouseCoopers LLP (Canada)
 PricewaterhouseCoopers LLP (Canada) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLP provides accounting services. The firm provides industry focused assurance, advisory and tax services for public, private and government clients in four areas such as corporate accountability, risk management, structuring and mergers and acquisitions and performance and process improvement. Its services include consulting, deals, risk assurance services and insolvency assignments. The company was founded on July 1, 1998 and is headquartered in Toronto, Canada. | 6 years |
| Mark Tommasi | M | 51 | 2 years | |
| Gordon Reykdal | M | - | 2 years | |
| Arthur Kwan | M | 52 | 6 years | |
| Hugh Aird | M | 70 | 6 years | |
| Martin LeBlanc | M | 58 |
Victhom Laboratory, Inc.
 Victhom Laboratory, Inc. Medical SpecialtiesHealth Technology Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada. | 17 years |
| Karin A. McCaskill | F | - | 4 years | |
| Sabrina Heltz | F | 59 | 4 years | |
| George Hornig | M | 69 | - | |
| Vahan Ajamian | M | - | 4 years | |
| John Arbuthnot | M | 34 | 12 years | |
| Margarita Simkin | F | - | 4 years | |
| Ian Chadsey | M | - | 5 years | |
| Karine Tendland | F | - |
Victhom Laboratory, Inc.
Victhom Laboratory, Inc. Medical SpecialtiesHealth Technology Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada. | 20 years |
| Andrea Elliott | F | - | 3 years | |
| Max Hoyt | M | - | 12 years | |
| Jeff Fallows | M | - | 5 years | |
| J. Paul SoRelle | M | 67 | 10 years | |
| Sarah Choukah | F | - |
Hyasynth Biologicals, Inc.
 Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | - |
| Alex Campbell | M | - |
Hyasynth Biologicals, Inc.
Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | - |
| Shoham Mookerjee | M | - |
Hyasynth Biologicals, Inc.
Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | - |
| Kevin Chen | M | - |
Hyasynth Biologicals, Inc.
Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | 10 years |
| Zach Wiltshire | M | - |
Hyasynth Biologicals, Inc.
Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | - |
| Daniel Johnson | M | 79 |
Victhom Laboratory, Inc.
Victhom Laboratory, Inc. Medical SpecialtiesHealth Technology Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada. | 22 years |
| Timothy Smokoff | M | 59 | 6 years | |
| Christian Grunt | M | - | 4 years | |
| Christian Sinclair | M | - | 4 years | |
| Stuart Starkey | M | - | 2 years | |
| Eric Hoskins | M | 63 | 1 years | |
| Jonathan Bolduc | M | - |
Desjardins Securities, Inc.
 Desjardins Securities, Inc. Investment Banks/BrokersFinance Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF). | 18 years |
| Shatony Sargeant | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Costine | M | - | 2 years | |
| Normand Rivard | M | - |
Victhom Laboratory, Inc.
Victhom Laboratory, Inc. Medical SpecialtiesHealth Technology Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada. | - |
| Michael Dalsin | M | 53 | 3 years | |
| Robert Kusher | M | - | - | |
| Roger Greene | M | 69 | 7 years | |
| Thomas Gerstenecker | M | 56 | 1 years | |
| Ken Villazor | M | 56 | 3 years | |
| David Hayes | M | - | 1 years | |
| Neil Berman | M | - |
Delivra, Inc. (Indiana)
 Delivra, Inc. (Indiana) Packaged SoftwareTechnology Services Delivra, Inc. provides digital marketing software and services by email. The firm services include email marketing, strategy, design and reporting. The company was founded by Neil Berman in 1999 and is headquartered in Indianapolis, IN. | 18 years |
| Jacob Gamble | M | - | - | |
| Andrew Folmer | M | - | 1 years | |
| Lana Fiset | F | - |
Victhom Laboratory, Inc.
Victhom Laboratory, Inc. Medical SpecialtiesHealth Technology Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada. | 3 years |
| Raza Bokhari | M | 57 | 3 years | |
| Leonard J. Cox | M | 52 | 2 years | |
| Gerald Goldberg | M | 81 |
PsyBio Therapeutics Corp.
 PsyBio Therapeutics Corp. BiotechnologyHealth Technology PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Vancouver, Canada. | 3 years |
| Edward John Allera | M | - | 2 years | |
| Fahar Merchant | M | - | 6 years | |
| Michael King Lam | M | - |
MGI Securities, Inc.
 MGI Securities, Inc. Investment Banks/BrokersFinance Founded in 2000, MGI Securities, Inc., formerly McFarlane Gordon, Inc., is a broker/dealer headquartered in Toronto with an additional office in Calgary. The firm is a subsidiary of Jovian Capital Corp. (TSX: JVN). They provide a range of specialized services for institutional investors and professional private wealth management solutions for individual investors. MGI Securities does not provide any internal research. MGI Securities is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF). The firm is a participating organization in the Toronto Stock Exchange, the TSX Venture Exchange and the Canadian Trading and Quotation System Inc. (CNQ) through their PURE Trading Facility, Alpha Trading Systems, Omega ATS and Chi-X Canada. | - |
| Jack Geltosky | M | 78 | 12 years | |
| David Mitchell | M | 61 | 2 years | |
| Paul Rosen | M | 60 | 1 years | |
| Brent Bottomley | M | - | - | |
| Peter Gibson | M | - |
Desjardins Securities, Inc.
Desjardins Securities, Inc. Investment Banks/BrokersFinance Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF). | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 72 | 72.00% |
| United States | 30 | 30.00% |
| India | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nitin Kaushal
- Personal Network
